Table 1.

Patient and treatment characteristics. Patients were staged retrospectively using the 2009 AJCC cancers staging system. Note that most patients were treated in the postoperative setting with conventionally fractionated radiation therapy.

Patient	Age	Sex	Site	Histologic subtype	T	N	M	Surgery	Margins	XRT	XRT Dose (Gy)	XRT fractionation	Immuno	Chemo
1	57	Female	Sinonasal	Mucosal melanoma, NOS	T1	N0	M0	Yes	Negative	Yes	58.9	1.2 b.i.d.	Yes	No
2	65	Male	Oral cavity	Mucosal melanoma, NOS	T1	N0	M0	Yes	Negative	Yes	60	2 daily	No	No
3	64	Male	Oral cavity	Mucosal melanoma, NOS	T4	N0	M0	Yes	Negative	No			No	No
4	27	Male	Sinonasal	Mucosal melanoma, NOS	T4	N0	M0	Yes	Negative	Yes	59.4	1.8 daily	No	No
5	61	Female	Sinonasal	Mucosal melanoma, NOS	T4	N0	M0	Yes	Negative	Yes	59.4	1.8 daily	Yes	No
6	77	Female	Sinonasal	Mucosal melanoma, NOS	T3	N0	M0	Yes	Positive	Yes	59.4	1.8 daily	Yes	No
7	46	Female	Sinonasal	Mucosal melanoma, NOS	T1	N0	M0	Yes	Negative	Yes	unk		Yes	No
8	62	Female	Sinonasal	Spindle cell melanoma	T3	N0	M0	Yes	Negative	Yes	unk		Yes	No
9	76	Female	Sinonasal	Mucosal melanoma, NOS	T1	N0	M0	Yes	Negative	Yes	unk		No	No
10	65	Male	Oral cavity	Mucosal melanoma, NOS	T1	N2b	M0	Yes	Negative	Yes	62	2 daily	Yes	No
11	68	Male	Sinonasal	Mucosal melanoma, NOS	T2	N0	M0	Yes	Negative	No			No	No
12	82	Male	oral cavity	Spindle cell melanoma	Tx	N0	M0	Yes	Negative	No			No	No
13	74	Female	Sinonasal	Spindle cell melanoma	T3	N0	M0	No	N/A	Yes	61.2	1.8 daily	No	Yes
14	83	Female	Sinonasal	Mucosal melanoma, NOS	T3	N0	M0	Yes	Negative	Yes	54	1.8 daily	Yes	No
15	51	Female	Oral cavity	mucosal melanoma, NOS	T4	N2a	M0	Yes	Positive	Yes	60	2 daily	No	No
16	77	Male	Sinonasal	Mucosal melanoma, NOS	T4	N0	M0	Yes	Positive	No			No	No
17	66	Female	Oral cavity	Spindle cell melanoma	T1	N0	M0	Yes	Negative	No			No	No